Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New agents for schizophrenia discovered at Warner-Lambert

Sep. 20, 1999

Selective brain GABA-A receptor ligands in the Neurogen pipeline

Sep. 20, 1999

Neurogen patents potent and selective D4 antagonists

Sep. 20, 1999

New, orally active EP1 receptor antagonist assessed for effects in pain models

Sep. 17, 1999

Pharmacological characterization of new sodium channel blocker: RS-132943

Sep. 17, 1999

NK1 receptor antagonist from Servier proves effective in models of chronic neuropathic pain

Sep. 17, 1999

Amrad presents first data on AM-336 and AM-543 at international congress

Sep. 17, 1999

New fentanyl-like opioid analgesic profiled at recent European congresses

Sep. 17, 1999

Presentation of preliminary phase II results with DepoMorphine at World Congress on Pain

Sep. 17, 1999

Positive AMPA receptor modulators developed and evaluated at NeuroSearch

Sep. 17, 1999

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...